CYCLADIC ART MUSEUM, 11/02/2015 On Wednesday, 11 February 2015 at the Cycladic Art Museum, pharma Q, a member of the ΙΑSIS group of companies, organized a scientific meeting for pharmacists under the title “IASIS (Cure): By the hand of the Pharmacist”. The lectures, which were very well received by the audience concerned two of the most [...]
ATHENS LEDRA HOTEL, ATHENS, 13/12/2014 IASIS PHARMA participated, as it consistently does every year, in the Annual Winter Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the ATHENS LEDRA HOTEL, in Athens, on 13 December 2014. IASIS PHARMA stand was visited by a high number of Dermatologists where three (3) [...]
KEDEA HALL OF THE ARISTOTLE UNIVERSITY OF THESSALONIKI, 19-20/09/2014 The Greek Association of Alzheimer’s Disease in cooperation with the Angelopoulos Foundation, the ΑSPAD and ΕνΝΟΗΣΗΣ research programs of the AUT and the PanHellenic Institute of Neurodegenerative Diseases organized a scientific conference under the title: “Moral Dilemmas and New Technologies in the treatment of Dementia” that took place [...]
Pharma Q, a member of IASIS PHARMA group of companies, has launched a new pharmaceutical product under the brand name Licosil (Sildenafil) to treat erectile dysfunction. Licosil is the 1st generic sildenafil, which has been successfully launched in the Greek pharmaceutical market by a Greek pharmaceutical industry in τwο strengths: 50 and 100 mg respectively [...]
DIVANI CARAVEL HOTEL, ATHENS, 21/06/2014 IASIS PHARMA participated, as it consistently does every year, in the Annual Summer Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the DIVANI CARAVEL HOTEL Athens, on 21 June 2014. IASIS PHARMA has a strong and long-lasting relation with the field of Dermatology and has [...]
IASIS PHARMA has launched a new pharmaceutical product under the brand name Lartokaz. It is an Irbesartan/hydrochlorothiazide combination preparation in two strengths: (150+12,5)mg/tab and (300+12,5)mg/tab respectively. Irbesartan is an angiotensin II receptor antagonist used mainly for the treatment of hypertension and in a combination formulation with hydrochlorothiazide(diuretic), is able to achieve an additive antihypertensive effect.
IASIS PHARMA has launched a new pharmaceutical product under the brand name Raberen (as rabeprazole sodium). Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. Raberen in either 10 or 20 mg form of gastro-resistant tablets, is the 1st generic rabeprazole, which has been successfully launched in the Greek pharmaceutical market by [...]
HYATT REGENCY HOTEL, THESSALONIKI, 12/04/2014 IASIS PHARMA participated, as it consistently does every year, in the Annual Spring Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the HYATT REGENCY HOTEL Thessaloniki, on 12 April 2014. IASIS PHARMA stand was visited by a high number of Dermatologists where three (3) of its [...]
IASIS PHARMA has launched a new pharmaceutical product under the brand name Contrahist (as levocetirizine dihydrochloride). It is a non-sedative antihistamine and is available as 5 mg-strength f.c tablets and a 0.5 mg/mL oral solution. Contrahist is the 1st generic levocetirizine, which has been successfully launched in the Greek pharmaceutical market by a Greek pharmaceutical [...]
BIOMEDICAL RESEARCH FOUNDATION AMPITHEATRE, ATHENS, 15/03/2014 IASIS PHARMA successfully participated in the 19th Hellenic Conference for Helicobacter Pylori and Other Infections of the Peptic System that took place at the amphitheater of the Biomedical research Foundation, Athens, 15 March 2014, organized by the Hellenic Society for the Study of H pylori. Congress invitees included distinguished gastroenterologists [...]
